{"id":1686118,"date":"2025-05-27T07:45:15","date_gmt":"2025-05-27T09:45:15","guid":{"rendered":"https:\/\/teknomers.com\/fr\/dans-le-bon-sens-lanalyste-de-barclay-ose-faire-plus-de-bayer-a-partager-firm\/"},"modified":"2025-05-27T07:45:20","modified_gmt":"2025-05-27T09:45:20","slug":"dans-le-bon-sens-lanalyste-de-barclay-ose-faire-plus-de-bayer-a-partager-firm","status":"publish","type":"post","link":"https:\/\/teknomers.com\/fr\/dans-le-bon-sens-lanalyste-de-barclay-ose-faire-plus-de-bayer-a-partager-firm\/","title":{"rendered":""Dans le bon sens": L’analyste de Barclay ose faire plus de bayer \u00e0 partager Firm."},"content":{"rendered":"


\n<\/p>\n

La British Investment Bank Barclays a relev\u00e9 l’objectif de cours de Bayer de 22 \u00e0 25 euros, mais a laiss\u00e9 la classification \u00e0 “un poids \u00e9gal”.<\/p>\n

\n

Gr\u00e2ce au solide d\u00e9veloppement des affaires pharmaceutiques au premier trimestre, les Leverkuseners pourraient se retrouver dans ce domaine sur les destinations annuelles, a \u00e9crit Emily Field dans son commentaire mardi. Les activit\u00e9s agricoles et consommateurs de Bayer sont en bonne voie d’atteindre leurs objectifs.\n<\/p>\n

En mardi n\u00e9gociant sur Xetra, la part de Bayer augmente temporairement de 1,28% \u00e0 25,00 euros.\n<\/p>\n

\/ Ag \/ GL<\/p>\n

Publication de l’\u00e9tude originale: 27.05.2025 \/ 03:25 \/ GMT pour la premi\u00e8re fois en transmettant l’\u00e9tude originale: 27.05.2025 \/ 03:29 \/ GMT<\/p>\n

Londres (DPA-AFX)<\/p>\n<\/div>\n

\n

Produits de levier s\u00e9lectionn\u00e9s sur Bayer<\/h2>\n

Avec les KO, les investisseurs sp\u00e9culatifs peuvent participer de mani\u00e8re disproportionn\u00e9e aux mouvements des prix. Choisissez simplement le levier souhait\u00e9 et nous vous montrerons des produits ouverts appropri\u00e9s sur Bayer<\/p>\n

Le levier doit \u00eatre compris entre 2 et 20<\/p>\n

Publicit\u00e9<\/span><\/div>\n


\n
ttn-fr-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

La British Investment Bank Barclays a relev\u00e9 l’objectif de cours de Bayer de 22 \u00e0 25 euros, mais a laiss\u00e9 la classification \u00e0 “un poids \u00e9gal”. Gr\u00e2ce au solide d\u00e9veloppement des affaires pharmaceutiques au premier trimestre, les Leverkuseners pourraient se retrouver dans ce domaine sur les destinations annuelles, a \u00e9crit Emily Field dans son commentaire […]<\/p>\n","protected":false},"author":1,"featured_media":1686119,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[14462,6460,4226,365,42221,18788,5060,1222,21808,88813],"class_list":["post-1686118","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-barclay","tag-bayer","tag-bon","tag-faire","tag-firm","tag-lanalyste","tag-ose","tag-partager","tag-quotdans","tag-sensquot"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/1686118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/comments?post=1686118"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/posts\/1686118\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media\/1686119"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/media?parent=1686118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/categories?post=1686118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/fr\/wp-json\/wp\/v2\/tags?post=1686118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}